FDA Drug Application (090519) for ABACAVIR SULFATE; LAMIVUDINE by MATRIX LABS LTD

Back to FDA Applications sponsored by MATRIX LABS LTD

Application Number090519
Product Number001
FormTABLET; ORAL
Dosage600MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR SULFATE; LAMIVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient ABACAVIR SULFATE9
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by MATRIX LABS LTD